Dopamine Toxicity Induces ROS-Dependent Death of Murine Neuroblastoma Cells: Impact on the Interactions of Cofilin

Tapasi Roy1, Rachana Banerjee2, Abhishek Chatterjee1

  • 1Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Jadavpur, Kolkata, West Bengal, 700032, India.

PubMed

Insights

Elevated dopamine in Parkinson's disease causes cell death by damaging the neuronal cytoskeleton and altering protein interactions. This research opens new avenues for targeted drug development to combat the disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Parkinson's disease (PD) is characterized by dopaminergic neuron loss.
  • This loss results in increased dopamine levels in the brain's micro-environment.
  • The impact of this elevated dopamine on neuronal structures and protein interactions is not fully understood.

Purpose of the Study:

  • To investigate the effects of high dopamine concentration on neuronal protein interactions and cytoskeleton stability.
  • To elucidate the mechanisms underlying dopamine-induced neurotoxicity.

Main Methods:

  • Murine neuroblastoma N2A cells were exposed to elevated dopamine (100 µM).
  • Assays included cell death evaluation, reactive oxygen species (ROS) measurement, gene expression analysis (RT-PCR), protein analysis (Western blotting, co-immunoprecipitation), enzyme activity assays (zymography), mitochondrial potential assessment, and in-silico modeling.
  • Confocal imaging was used to visualize cellular changes.

Main Results:

  • Elevated dopamine induced ROS-dependent apoptotic cell death.
  • Transcriptional and protein levels of alpha-synuclein, UCHL1, and cofilin were altered.
  • Matrix metalloproteinases9 (MMP9) activity and expression increased, indicating neuro-inflammation.
  • Actin cytoskeleton degradation and altered Cofilin-UCHL1/MMP9 interactions were observed, confirmed by in-silico and co-immunoprecipitation studies.

Conclusions:

  • Dopamine toxicity in a Parkinson's disease-like environment disrupts intracellular protein interactions and degrades the neuronal cytoskeleton, leading to cell death.
  • These findings suggest novel therapeutic strategies targeting dopamine-altered protein interactions for PD treatment.